Abstract:Abstract Recent advances in genome-wide DNA methylation (DNAm) profiling for smoking behaviour have given rise to a new, molecular biomarker of smoking exposure. It is unclear whether a smoking-associated DNAm (epigenetic) score has predictive value for ageing-related health outcomes which is independent of contributions from self-reported (phenotypic) smoking measures. Blood DNA methylation levels were measured in 895 adults aged 70 years in the Lothian Birth Cohort 1936 (LBC1936) study using the Illumina 450K assay. A DNA methylation score based on 230 CpGs was used as a proxy for smoking exposure. Associations between smoking variables and health outcomes at age 70 were modelled using general linear modelling (ANCOVA) and logistic regression. Additional analyses of smoking with brain MRI measures at age 73 ( n = 532) were performed. Smoking-DNAm scores were positively associated with self-reported smoking status ( P < 0.001, eta-squared ɳ 2 = 0.63) and smoking pack years ( r = 0.69, P < 0.001). Higher smoking DNAm scores were associated with variables related to poorer cognitive function, structural brain integrity, physical health, and psychosocial health. Compared with phenotypic smoking, the methylation marker provided stronger associations with all of the cognitive function scores, especially visuospatial ability ( P < 0.001, partial eta-squared ɳ p 2 = 0.022) and processing speed ( P < 0.001, ɳ p 2 = 0.030); inflammatory markers (all P < 0.001, ranges from ɳ p 2 = 0.021 to 0.030); dietary patterns (healthy diet ( P < 0.001, ɳ p 2 = 0.052) and traditional diet ( P < 0.001, ɳ p 2 = 0.032); stroke ( P = 0.006, OR 1.48, 95% CI 1.12, 1.96); mortality ( P < 0.001, OR 1.59, 95% CI 1.42, 1.79), and at age 73; with MRI volumetric measures (all P < 0.001, ranges from ɳ p 2 = 0.030 to 0.052). Additionally, education was the most important life-course predictor of lifetime smoking tested. Our results suggest that a smoking-associated methylation biomarker typically explains a greater proportion of the variance in some smoking-related morbidities in older adults, than phenotypic measures of smoking exposure, with some of the accounted-for variance being independent of phenotypic smoking status.

Tobacco Smoking and Smoking-Related DNA Methylation Are Associated with the Development of Frailty among Older Adults.

Smoking-Related DNA Methylation is Associated with DNA Methylation Phenotypic Age Acceleration: the Veterans Affairs Normative Aging Study

Relationship Of Tobacco Smoking And Smoking-Related Dna Methylation With Epigenetic Age Acceleration

From tobacco smoking to mutational signature: the role of epigenetic changes in human cancers

Dna Methylation Changes in Response to Active Smoking Exposure Are Associated with Leukocyte Telomere Length among Older Adults

Associations of self-reported smoking, cotinine levels and epigenetic smoking indicators with oxidative stress among older adults: a population-based study

Tobacco Smoking and Methylation of Genes Related to Lung Cancer Development.

Epigenome‐wide analysis of frailty: Results from two European twin cohorts

Exploring the Cross-Cancer Effect of Smoking and Its Fingerprints in Blood DNA Methylation on Multiple Cancers: A Mendelian Randomization Study

Secondhand smoke is positively associated with pre-frailty and frailty in non-smoking older adults

The impact of methylation quantitative trait loci (mQTLs) on active smoking-related DNA methylation changes

Epigenetic signatures of smoking associate with cognitive function, brain structure, and mental and physical health outcomes in the Lothian Birth Cohort 1936

Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation

From Tobacco Smoking to Cancer Mutational Signature: a Mediation Analysis Strategy to Explore the Role of Epigenetic Changes

The association of cigarette smoking with DNA methylation and gene expression in human tissue samples

Genome-Wide Analysis of DNA Methylation and Cigarette Smoking in a Chinese Population

Tobacco and alcohol consumption and the risk of frailty and falling: a Mendelian randomisation study

Epigenome-wide association study of whole blood gene expression in Framingham Heart Study participants provides molecular insight into the potential role of CHRNA5 in cigarette smoking-related lung diseases

Smoking induces coordinated DNA methylation and gene expression changes in adipose tissue with consequences for metabolic health

Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiency

Novel DNA methylation sites associated with cigarette smoking among African Americans